Tarsus Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TARS Nasdaq 8731 https://www.tarsusrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tarsus Pharmaceuticals Inc

Tarsus to Present at the Jefferies Global Healthcare Conference - Jun 5th, 2023 12:30 pm
Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements - May 9th, 2023 8:05 pm
Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers - May 8th, 2023 12:30 pm
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - May 5th, 2023 12:22 pm
Tarsus to Participate at the Bank of America 2023 Healthcare Conference - May 3rd, 2023 8:30 pm
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer - Apr 24th, 2023 12:30 pm
Tarsus Pharmaceuticals, Inc. (TARS) Soars 8.6%: Is Further Upside Left in the Stock? - Apr 18th, 2023 10:04 am
Shareholders in Tarsus Pharmaceuticals (NASDAQ:TARS) are in the red if they invested a year ago - Apr 6th, 2023 7:52 pm
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Is Expected To Breakeven In The Near Future - Mar 17th, 2023 10:28 am
Tarsus Reports Full-Year 2022 Financial Results and Recent Business Achievements - Mar 13th, 2023 8:05 pm
Will Provention Bio, Inc. (PRVB) Report Negative Earnings Next Week? What You Should Know - Mar 9th, 2023 3:00 pm
Tarsus to Present at Upcoming Investor Conferences - Mar 2nd, 2023 9:30 pm
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) insiders placed bullish bets worth US$1.6m in the last 12 months - Feb 24th, 2023 4:44 pm
Strength Seen in Tarsus Pharmaceuticals, Inc. (TARS): Can Its 5.0% Jump Turn into More Strength? - Jan 24th, 2023 9:33 am
Tarsus Added to NASDAQ Biotechnology Index - Dec 16th, 2022 12:00 pm
Tarsus Pharma Touts Positive Data For Experimental Drug For Tick-Borne Disease - Dec 15th, 2022 5:45 pm
Tarsus Announces Positive Topline Data from Phase 1b Callisto Trial and Initiates Phase 2a Carpo Human Tick Kill Trial Evaluating TP-05, A Novel, Oral Therapeutic for the Prevention of Lyme Disease - Dec 15th, 2022 1:30 pm
Institutional investors own a significant stake of 41% in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Dec 8th, 2022 11:55 am
Tarsus Pharmaceuticals Third Quarter 2022 Earnings: US$0.84 loss per share (vs US$0.76 loss in 3Q 2021) - Nov 11th, 2022 11:03 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Misses Revenue Estimates - Nov 9th, 2022 1:45 pm